Ondine Biomedical Inc. (OBI.L)
GBp 8.13
(4.84%)
GBp 8.13
(4.84%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -2.44 Million CAD | 80.05% |
| 2022 | -12.22 Million CAD | 58.72% |
| 2021 | -29.62 Million CAD | -196.09% |
| 2020 | 30.83 Million CAD | 11.16% |
| 2019 | 27.73 Million CAD | 42.35% |
| 2018 | 19.48 Million CAD | 116.19% |
| 2017 | 9.01 Million CAD | 0.0% |
| 2010 | -376.54 Thousand CAD | 64.33% |
| 2009 | -1.05 Million CAD | -2.18% |
| 2008 | -1.03 Million CAD | 77.24% |
| 2007 | -4.54 Million CAD | -0.38% |
| 2006 | -4.52 Million CAD | -50.63% |
| 2005 | -3 Million CAD | 0.0% |
| 2003 | -667.00 CAD | -100.29% |
| 2002 | 233.01 Thousand CAD | 5028.34% |
| 2001 | -4728.00 CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -3.7 Million CAD | 0.0% |
| 2023 Q4 | -2.44 Million CAD | 0.0% |
| 2023 FY | -2.44 Million CAD | 80.05% |
| 2022 Q2 | -20.2 Million CAD | 0.0% |
| 2022 FY | -12.22 Million CAD | 58.72% |
| 2022 Q4 | -12.22 Million CAD | 0.0% |
| 2021 Q2 | 32.82 Million CAD | 0.0% |
| 2021 FY | -29.62 Million CAD | -196.09% |
| 2021 Q4 | -29.62 Million CAD | 0.0% |
| 2020 Q4 | 30.83 Million CAD | 0.0% |
| 2020 FY | 30.83 Million CAD | 11.16% |
| 2019 FY | 27.73 Million CAD | 42.35% |
| 2018 FY | 19.48 Million CAD | 116.19% |
| 2017 FY | 9.01 Million CAD | 0.0% |
| 2011 Q2 | 1.67 Million CAD | 324.67% |
| 2011 Q1 | 395.05 Thousand CAD | 204.91% |
| 2010 Q3 | -59.64 Thousand CAD | 52.94% |
| 2010 Q1 | -1.23 Million CAD | -16.87% |
| 2010 FY | -376.54 Thousand CAD | 64.33% |
| 2010 Q2 | -126.74 Thousand CAD | 89.73% |
| 2010 Q4 | -376.54 Thousand CAD | -531.3% |
| 2009 Q4 | -1.05 Million CAD | -10.68% |
| 2009 FY | -1.05 Million CAD | -2.18% |
| 2009 Q1 | -439.88 Thousand CAD | 57.43% |
| 2009 Q3 | -953.9 Thousand CAD | 12.08% |
| 2009 Q2 | -1.08 Million CAD | -146.64% |
| 2008 Q4 | -1.03 Million CAD | -45.3% |
| 2008 FY | -1.03 Million CAD | 77.24% |
| 2008 Q1 | -1.59 Million CAD | 64.79% |
| 2008 Q2 | -3.18 Million CAD | -99.43% |
| 2008 Q3 | -711.09 Thousand CAD | 77.7% |
| 2007 Q3 | -1.08 Million CAD | 36.96% |
| 2007 Q4 | -4.54 Million CAD | -319.44% |
| 2007 Q2 | -1.71 Million CAD | -8.24% |
| 2007 Q1 | -1.58 Million CAD | 64.93% |
| 2007 FY | -4.54 Million CAD | -0.38% |
| 2006 FY | -4.52 Million CAD | -50.63% |
| 2006 Q4 | -4.52 Million CAD | -245.31% |
| 2006 Q3 | -1.3 Million CAD | 43.61% |
| 2006 Q2 | -2.32 Million CAD | 19.74% |
| 2006 Q1 | -2.89 Million CAD | 3.62% |
| 2005 Q1 | -2.04 Million CAD | -62.12% |
| 2005 Q4 | -3 Million CAD | 25.44% |
| 2005 Q3 | -4.02 Million CAD | 64.16% |
| 2005 Q2 | -11.23 Million CAD | -448.29% |
| 2005 FY | -3 Million CAD | 0.0% |
| 2004 Q3 | -5.04 Million CAD | 68.04% |
| 2004 Q2 | -15.77 Million CAD | -955.58% |
| 2004 Q1 | -1.49 Million CAD | -2475.52% |
| 2004 Q4 | -1.26 Million CAD | 74.92% |
| 2003 Q4 | -58.02 Thousand CAD | -8599.25% |
| 2003 FY | -667.00 CAD | -100.29% |
| 2003 Q1 | -284.00 CAD | 94.15% |
| 2003 Q3 | -667.00 CAD | 61.67% |
| 2003 Q2 | -1740.00 CAD | -512.68% |
| 2002 FY | 233.01 Thousand CAD | 5028.34% |
| 2002 Q2 | 41.14 Thousand CAD | 11562.12% |
| 2002 Q3 | 233.01 Thousand CAD | 466.26% |
| 2002 Q4 | -4853.00 CAD | -102.08% |
| 2002 Q1 | -359.00 CAD | -35.47% |
| 2001 Q4 | -265.00 CAD | 0.0% |
| 2001 FY | -4728.00 CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|